MIMG 170: Cell and Gene Therapy
State-of-art study of stem cells and gene therapy, and approaches to treat congenital/genetic defects, diseases, or injuries in humans. Review of current knowledge of human stem cells and viral and non-viral gene delivery strategies, and how they can be safely evaluated in animal models of disease. Introduction to ethical and legal issues related to cell and gene therapy as well as how to translate therapies into practice including aspects of cell and gene therapy intellectual property, regulatory, and Food and Drug Administration considerations. Includes innovative mock company team pitches to venture capitalists to learn how to raise capital for their new inventions based on what they have learned.
4 units, lecture, discussion
Loading...
| APRIL DAWN PYLE | Spring 2026 | 49 | 98.0% (48) |
|---|
A-range % and grade counts cover only each instructor’s latest recorded term, shown in the "Latest Data From" column, combining all sections for the course. A-range % is the share of recorded letter grades (A+ through F) that are A+, A, or A−. Parentheses show the A-range count over the total letter-grade count. P/NP and incompletes are excluded. Records may be incomplete.
- Available Academic Terms
- Spring 2022 · Spring 2023 · Spring 2024 · Spring 2025 · Spring 2026